- recruitingPHASE3
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
This study is looking at a new medicine called Tanruprubart (also known as ANX005) for people with Guillain-Barré Syndrome (GBS). It aims to see how safe the medicine is, how it works in the body, and if it helps people get better. The study includes adults and children aged 8-85.
United States · Denmark · France - recruiting
Living With Guillain-Barré Syndrome as Children.
This study looks at how children aged 10 and older feel years after having Guillain-Barré Syndrome (GBS). Researchers want to understand their memories and feelings to improve care and support for children recovering from this condition.
France - enrolling by invitationNA
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
This study looks at how walking aids and training can help people with certain muscle and nerve conditions fall less often. It aims to improve their safety and daily life by finding the best ways to use these aids.
Germany